Current stock page

Financial Data

BHVN Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

BHVNBiohaven Ltd.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

BearishEdge 8/10
$13.82−$0.25 (−1.78%)

Latest quote

  • Momentum
    78
  • Value
    —
  • Quality
    16
  • Risk resilience
    35
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$0$0$0$0$0$0$0$0
Gross Profit$0$0$0-$960K-$1.11M$0$0$0
Operating Income-$126.42M-$124.9M-$130.43M-$142.73M-$169.38M-$211.7M-$221.56M-$189.93M
Net Income-$129.28M-$137.31M-$130.53M-$145.56M-$173.44M-$198.15M-$221.68M-$186.84M
EPS-$0.86-$0.91-$0.88-$1.21-$1.64-$1.94-$2.17-$1.85
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow-$106.85M-$85.1M-$149.92M-$130.66M-$145.72M-$167.94M-$165.12M-$170.74M
Capital Expenditure-$180K-$454K$0-$8K-$13K-$233K-$461K-$49K
Free Cash Flow-$107.03M-$85.55M-$149.92M-$130.67M-$145.73M-$168.17M-$165.59M-$170.79M
Net Cash Provided By Operating Activities-$106.85M-$85.1M-$149.92M-$130.66M-$145.72M-$167.94M-$165.12M-$170.74M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$263.68M$370.74M$466.41M$451.45M$409.12M$550.42M$458.95M$615.11M
Total Debt$300.44M$297.04M$286.18M$284.61M$314.18M$291.56M$35.51M$36.58M
Cash And Cash Equivalents$95.75M$238.03M$273.07M$229.96M$184.85M$165.8M$98.42M$99.13M
Total Liabilities$361.92M$358.52M$336.91M$399.38M$426.28M$415.83M$199.45M$191.67M
Total Stockholders Equity-$98.25M$12.22M$129.5M$52.07M-$17.16M$134.59M$259.5M$423.44M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio—179.2111.5627.26—10.28.087.65
P/S ratio————————
Debt To Equity—24.32.215.47—2.170.140.09
Free Cash Flow Yield-19.00%-23.37%-39.72%-42.99%-78.89%-47.09%-30.96%-18.10%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio————————
P/B ratio—179.2111.5627.26—10.28.087.65
P/S ratio————————
Return On Equity—-48.02%-5.00%-14.19%—-5.70%-3.42%-199.89%
Debt To Equity—24.32.215.47—2.170.140.09

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe-3.58x
Pb-21.25x
EPS Growth Yoy47.56%
Gross Margin0.00%
Operating Margin0.00%
ROE-2271.87%
ROIC-255.03%
Debt To Equity-3.06
FCF Yield-22.67%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$13.82
Volume1.26M
RSI (14)47.8
MACD0.37
MACD signal0.48
MACD histogram-0.12
ADX (14)24.51
SMA (50)$13.52
SMA (200)$12.33
ATR (14)$1.04
Historical volatility (annualized)114.51%
Volume (20-day average)3.82M

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score35/100
Beta1.28
Annual volatility82.98%
Max Drawdown-41.21%
Sharpe Ratio1
VaR (95%, 1-day)-6.75%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

BHVN Financial Data FAQ

What is Biohaven Ltd.'s revenue?

Biohaven Ltd.'s revenue is one of the core financial data points for BHVN. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Biohaven Ltd.'s revenue growing?

Revenue growth shows whether Biohaven Ltd. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is BHVN's EPS?

BHVN's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Biohaven Ltd.'s net income?

Biohaven Ltd.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Biohaven Ltd. generate?

Free cash flow shows how much cash Biohaven Ltd. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Biohaven Ltd. have?

Cash and debt help frame BHVN's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.